Ligand Pharmaceuticals Incorporated Share Price

Ligand Pharmaceuticals Incorporated Share Price

NASDAQ: LGND | Mid Cap
$315.01
-$1.63 (-0.52%) Last updated on 29 Oct, 2026 | 20:40 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ligand Pharmaceuticals Incorporated Stock Performance

Open
$320.11
Prev. Close
$316.64
Circuit Range
N/A
Day Range
$319.31 - $323.46
Year Range
$176.10 - $323.51
Volume
3,635
Average Traded
$320.48

Ligand Pharmaceuticals Incorporated Share Price Today

As of 29 October 2026, Ligand Pharmaceuticals Incorporated's share price is $315.01. The stock opened at $320.11, compared to its previous close of $316.64. During today's trading session, Ligand Pharmaceuticals Incorporated's share price traded between $319.31 and $323.46, with an average price of $321.39. Over the past 52 weeks, the stock has recorded a high of $323.51 and a low of $176.10. In terms of performance, Ligand Pharmaceuticals Incorporated's share price has risen by 37.43% over the last six months and is up 63.91% on a year-on-year basis.

Ligand Pharmaceuticals Incorporated Share Price Chart

Line chart of the Ligand Pharmaceuticals Incorporated price trend over the selected period. The price fell overall, ranging from 312.49 to 323.46, ending at 315.01.
$319.31$323.46
L
Show Current Price
H

Ligand Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators

Market Cap
$6.09B
PE Ratio (TTM)
32.22
Dividend Yield
0.00%
EPS (TTM)
$9.89
Revenue (TTM)
$268.09B
Return On Equity (TTM)
20.38%
Profit Margin
46.42%
Debt to Equity
1.16
Quarterly Earnings Growth YoY
-58.63%

Ligand Pharmaceuticals Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$115.46$59.67$51.72$63.69
Net Profit$117.27$44.78-$13.35$48.51
Net Profit Margin101.57%75.05%-25.81%76.17%
Income ChangeN/A-61.81%-129.81%463.37%

Ligand Pharmaceuticals Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$196.25$131.31$167.13$268.09
Net Profit-$33.36$52.15-$4.03$124.45
Net Profit Margin-17.00%39.72%-2.41%46.42%
Income ChangeN/A256.32%-107.73%3188.09%

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Ligand Pharmaceuticals Incorporated Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$310.84
$319.31
+2.09%
Sep 2026
$285.38
$312.78
+9.99%
Aug 2026
$287.36
$284.37
-1.10%
Jul 2026
$309.34
$287.54
-8.97%
Jun 2026
$227.40
$315.86
+36.19%
May 2026
$227.63
$231.93
+1.18%
Apr 2026
$204.59
$229.22
+14.70%
Mar 2026
$199.41
$199.84
+0.68%
Feb 2026
$197.65
$198.50
+3.31%
Jan 2026
$189.97
$192.14
+1.60%
Dec 2025
$199.78
$189.11
-6.70%
Nov 2025
$191.59
$202.70
+5.47%

LGND Share Price FAQs